PANEL DISCUSSION: What is the Value Proposition for Digital Tools to Stakeholders in Clinical Research: Patients, Payers, HCPs, Regulators
Tim McCarthy, VP, Head of Digital Sciences & Translational Imaging, Pfizer
Rinol Alaj, Head of Digital Health Technologies, Regeneron
Gül Erdemli, Global Program Regulatory Director, Novartis
Daniel Kalanovic, VP, Head of Medical Digital Health, Pfizer
Led by Xuemei Cai, Sr. Director, Head of Clinical Research, Pfizer